Novo Nordisk
NVO
#102
Rank
โ‚น15.958 T
Marketcap
โ‚น3,578
Share price
0.28%
Change (1 day)
-46.61%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.799 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.744 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.903 T9.13%
2024 โ‚น1.744 T22.84%
2023 โ‚น1.419 T57.81%
2022 โ‚น899.74 B5.24%
2021 โ‚น854.98 B12.38%
2020 โ‚น760.78 B13.11%
2019 โ‚น672.61 B-3.45%
2018 โ‚น696.64 B1.88%
2017 โ‚น683.76 B4.3%
2016 โ‚น655.55 B10.32%
2015 โ‚น594.21 B7.47%
2014 โ‚น552.93 B3.4%
2013 โ‚น534.74 B19.09%
2012 โ‚น449.03 B15.58%
2011 โ‚น388.51 B16.58%
2010 โ‚น333.27 B25.66%
2009 โ‚น265.22 B10.68%
2008 โ‚น239.63 B55.82%
2007 โ‚น153.79 B7.02%
2006 โ‚น143.70 B19.05%
2005 โ‚น120.70 B10.55%
2004 โ‚น109.18 B
2002 โ‚น76.77 B-14.39%
2001 โ‚น89.67 B-52.82%
2000 โ‚น190.05 B250%
1999 โ‚น54.30 B31.21%
1998 โ‚น41.38 B34.31%
1997 โ‚น30.81 B11.46%
1996 โ‚น27.64 B9.03%
1995 โ‚น25.35 B-3.15%
1994 โ‚น26.17 B-0.67%
1993 โ‚น26.35 B45.38%
1992 โ‚น18.12 B-13.81%
1991 โ‚น21.03 B37.12%
1990 โ‚น15.33 B-0.79%
1989 โ‚น15.45 B26.2%
1988 โ‚น12.24 B24.97%
1987 โ‚น9.80 B-0.9%
1986 โ‚น9.89 B-7.78%
1985 โ‚น10.72 B24.87%
1984 โ‚น8.59 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.092 T-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.073 T 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น838.66 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น740.30 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA